Research and Markets: Global Opthalmic Therapeutic Market 2015 Report With Forecasts to 2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rspht4/global_opthalmic) has announced the addition of the "Global Opthalmic Therapeutic Market 2015-2019" report to their offering.

According to the report, the global ophthalmic therapeutic market will grow at a CAGR of 6.53% over the period 2014-2019. The incidence of eye diseases is increasing worldwide, particularly in industrialized and middle-income countries. Changing dietary habits, unhealthy lifestyles, and increased use of electronic equipment such as computers, TVs, and videogames affect normal eyesight. Smoking increases an individual's chances of developing AMD by 2-3 times.

Similarly, individuals with diets high in fat, cholesterol, and sugar and low in antioxidants are more likely to be affected by AMD. People with diabetes have a higher risk of being affected by diabetic retinopathy and macular edema. The population of people with diabetes is likely to increase from 382 million in 2013 to 592 million by 2035, leading to a rise in individuals with DME. The total number of cases of diabetic retinopathy is expected to increase from 4.89 million in 2012 to 7.17 million by 2022. The WHO classifies glaucoma as the second leading cause of visual impairment in the world, affecting about 285 million people worldwide.

Further, the report states that the limited public awareness of eye diseases restricts the market growth.

Key Topics Covered

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Disease Overview
  7. Pipeline Analysis
  8. Market Landscape
  9. Market Segmentation by Disease Type
  10. Market Segmentation by Route of Administration
  11. Market Segmentation by Molecule Type
  12. Market Segmentation by Dosage Form
  13. Geographical Segmentation
  14. Buying Criteria
  15. Market Growth Drivers
  16. Drivers and Their Impact
  17. Market Challenges
  18. Impact of Drivers and Challenges
  19. Market Trends
  20. Trends and Their Impact
  21. Vendor Landscape
  22. Key Vendor Analysis

Companies Mentioned

Partial list of the 60 companies featured in this comprehensive report:

  • Acadia Pharmaceuticals
  • Actavis
  • Bayer
  • BCN Peptides
  • Carl Zeiss Meditec
  • Eleven Biotherapeutics
  • F. Hoffmann-La Roche
  • Falcon Pharmaceuticals
  • Gilead Sciences
  • GlaxoSmithKline
  • Icon Bioscience
  • Lexicon Pharmaceuticals
  • Merck
  • Novartis
  • Ohr Pharmaceutical
  • PanOptica
  • Pfizer
  • Quark Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Seikagaku
  • StemCells
  • ThromboGenics
  • Valeant Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/rspht4/global_opthalmic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices